We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Hernia Repair With or Without Sutures
Updated: 12/31/1969
Sutures or No Sutures (SONS)
Status: Enrolling
Updated: 12/31/1969
Hernia Repair With or Without Sutures
Updated: 12/31/1969
Sutures or No Sutures (SONS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Updated: 12/31/1969
A Randomized, Multicenter, Phase II Trial of Cisplatin, Irinotecan and Bevacizumab (PCA) vs. Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Updated: 12/31/1969
A Randomized, Multicenter, Phase II Trial of Cisplatin, Irinotecan and Bevacizumab (PCA) vs. Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Updated: 12/31/1969
A Randomized, Multicenter, Phase II Trial of Cisplatin, Irinotecan and Bevacizumab (PCA) vs. Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Updated: 12/31/1969
A Randomized, Multicenter, Phase II Trial of Cisplatin, Irinotecan and Bevacizumab (PCA) vs. Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Updated: 12/31/1969
A Randomized, Multicenter, Phase II Trial of Cisplatin, Irinotecan and Bevacizumab (PCA) vs. Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Updated: 12/31/1969
A Randomized, Multicenter, Phase II Trial of Cisplatin, Irinotecan and Bevacizumab (PCA) vs. Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Updated: 12/31/1969
A Randomized, Multicenter, Phase II Trial of Cisplatin, Irinotecan and Bevacizumab (PCA) vs. Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Updated: 12/31/1969
A Randomized, Multicenter, Phase II Trial of Cisplatin, Irinotecan and Bevacizumab (PCA) vs. Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer
Updated: 12/31/1969
Phase II Trial of Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 12/31/1969
Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer
Updated: 12/31/1969
Phase II Trial of Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
Updated: 12/31/1969
Phase I Dose Escalation Study of Accelerated Fractionation With Esophageal Sparing Using Intensity-Modulated Radiation Therapy for Locally-Advanced Thoracic Malignancies Including a Prospective Assessment of Esophageal Motion and Radiation-Induced Esophageal Injury
Status: Enrolling
Updated: 12/31/1969
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
Updated: 12/31/1969
Phase I Dose Escalation Study of Accelerated Fractionation With Esophageal Sparing Using Intensity-Modulated Radiation Therapy for Locally-Advanced Thoracic Malignancies Including a Prospective Assessment of Esophageal Motion and Radiation-Induced Esophageal Injury
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Regulation of FGF21 by Nutritional Challenges
Updated: 12/31/1969
The Effect of Acute Nutritional Challenges on FGF21 Levels in Humans
Status: Enrolling
Updated: 12/31/1969
Regulation of FGF21 by Nutritional Challenges
Updated: 12/31/1969
The Effect of Acute Nutritional Challenges on FGF21 Levels in Humans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Updated: 12/31/1969
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated: 12/31/1969
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Updated: 12/31/1969
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Updated: 12/31/1969
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated: 12/31/1969
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Updated: 12/31/1969
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
Updated: 12/31/1969
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Status: Enrolling
Updated: 12/31/1969
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
Updated: 12/31/1969
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
Updated: 12/31/1969
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Status: Enrolling
Updated: 12/31/1969
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
Updated: 12/31/1969
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dronabinol Naltrexone Treatment for Opioid Dependence
Updated: 12/31/1969
Dronabinol Naltrexone Treatment for Opioid Dependence
Status: Enrolling
Updated: 12/31/1969
Dronabinol Naltrexone Treatment for Opioid Dependence
Updated: 12/31/1969
Dronabinol Naltrexone Treatment for Opioid Dependence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Use of an Ambulatory Capsule to Characterize Gastrointestinal Pressure Patterns in Children
Updated: 12/31/1969
Use of an Ambulatory Capsule to Characterize Gastrointestinal Pressure Patterns in Children
Status: Enrolling
Updated: 12/31/1969
Use of an Ambulatory Capsule to Characterize Gastrointestinal Pressure Patterns in Children
Updated: 12/31/1969
Use of an Ambulatory Capsule to Characterize Gastrointestinal Pressure Patterns in Children
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?
Updated: 12/31/1969
Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?
Status: Enrolling
Updated: 12/31/1969
Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?
Updated: 12/31/1969
Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?
Updated: 12/31/1969
Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?
Status: Enrolling
Updated: 12/31/1969
Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?
Updated: 12/31/1969
Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Lumbar Disc Herniation Outcome Measures
Updated: 12/31/1969
Lumbar Disc Herniation Outcome Measures-Surgical Versus Non-Operative Treatment
Status: Enrolling
Updated: 12/31/1969
Lumbar Disc Herniation Outcome Measures
Updated: 12/31/1969
Lumbar Disc Herniation Outcome Measures-Surgical Versus Non-Operative Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer
Updated: 12/31/1969
A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer
Updated: 12/31/1969
A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
Updated: 12/31/1969
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
Status: Enrolling
Updated: 12/31/1969
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
Updated: 12/31/1969
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastric Accommodation and Gastroesophageal Reflux
Updated: 12/31/1969
Gastric Accommodation as a Factor Influencing the Number of Reflux Episodes in Children and Adolescents
Status: Enrolling
Updated: 12/31/1969
Gastric Accommodation and Gastroesophageal Reflux
Updated: 12/31/1969
Gastric Accommodation as a Factor Influencing the Number of Reflux Episodes in Children and Adolescents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Molecular Anatomy of Oral Wound Healing
Updated: 12/31/1969
The Molecular Anatomy of Oral Wound Healing
Status: Enrolling
Updated: 12/31/1969
The Molecular Anatomy of Oral Wound Healing
Updated: 12/31/1969
The Molecular Anatomy of Oral Wound Healing
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Study of CB-183,315 in Participants With Clostridium Difficile Infection
Updated: 12/31/1969
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials